Dana-Farber Cancer Institute is a major cancer research and treatment center based in Massachusetts. It lobbies Congress to increase federal funding for cancer and biomedical research (including the NIH, National Cancer Institute, and ARPA‑H), to remove barriers to clinical trials, and to support bills improving childhood cancer research, survivorship, patient access, and related health program funding.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
CAROLINE POWERS
The latest disclosures for this client.
DANA-FARBER CANCER INSTITUTE
Q3DANA-FARBER CANCER INSTITUTE
Q2The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
DANA-FARBER CANCER INSTITUTE
DANA-FARBER CANCER INSTITUTE
Q1DANA-FARBER CANCER INSTITUTE
4ADANA-FARBER CANCER INSTITUTE
Q4DANA-FARBER CANCER INSTITUTE
Q3DANA-FARBER CANCER INSTITUTE
Q2DANA-FARBER CANCER INSTITUTE
Q1